Trade ALLO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Allogene Therapeutics, Inc. (ALLO) is trading at US$1.78, up 1.14% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$722.08M. Over the past 52 weeks, ALLO has traded between US$1.04 and US$4.46. On Syfe you can trade ALLO with $0 commission and add it to your watchlist.
| Previous close | US$1.76 |
|---|---|
| Market cap | US$722.08M |
| 52-week range | US$1.04 – US$4.46 |
| Volume | 3.88M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.
Year: 2018
Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says
Aug 13, 3:33 PM · MT Newswires
Allogene Therapeutics Q2 Loss Narrows
Aug 12, 8:57 PM · MT Newswires
--Earnings Flash (ALLO) Allogene Therapeutics Posts Q2 Loss $0.13 per Share, vs. FactSet Est of $0.17 Loss
Aug 12, 8:44 PM · MT Newswires
Allogene Therapeutics' Cemacabtagene Ansegedleucel Receives FDA RMAT, Fast Track Designations
Jul 29, 1:45 PM · MT Newswires
Allogene Therapeutics, Inc. (ALLO) stock is trading at US$1.78, +1.14% from the previous close of US$1.76.
The market cap for Allogene Therapeutics, Inc. (ALLO) stock is approximately US$722.08M.
The 52-week high for Allogene Therapeutics, Inc. (ALLO) stock is US$4.46.
The 52-week low for Allogene Therapeutics, Inc. (ALLO) stock is US$1.04.
Allogene Therapeutics, Inc. (ALLO) does not currently pay a dividend.
Stay on top of ALLO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
